Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?

Maiorano, BA; Catalano, M; Maiello, E; Roviello, G

Maiorano, BA (通讯作者)，IRCCS Casa Sollievo Sofferenza, Oncol Unit, San Giovanni Rotondo, Italy.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Metastatic urothelial carcinoma (mUC) is an aggressive malignancy with a dismal prognosis. Enfortumab vedotin (EV) is an antibody-drug conjugate consi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索